These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14499185)

  • 1. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro.
    Saul JM; Annapragada A; Natarajan JV; Bellamkonda RV
    J Control Release; 2003 Sep; 92(1-2):49-67. PubMed ID: 14499185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.
    Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A
    Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro.
    Lee RJ; Low PS
    Biochim Biophys Acta; 1995 Feb; 1233(2):134-44. PubMed ID: 7865538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
    J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
    Xiang G; Wu J; Lu Y; Liu Z; Lee RJ
    Int J Pharm; 2008 May; 356(1-2):29-36. PubMed ID: 18258394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid.
    Pan XQ; Zheng X; Shi G; Wang H; Ratnam M; Lee RJ
    Blood; 2002 Jul; 100(2):594-602. PubMed ID: 12091353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes.
    Zhao XB; Muthusamy N; Byrd JC; Lee RJ
    J Pharm Sci; 2007 Sep; 96(9):2424-35. PubMed ID: 17588260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes.
    Zhang Y; Guo L; Roeske RW; Antony AC; Jayaram HN
    Anal Biochem; 2004 Sep; 332(1):168-77. PubMed ID: 15301962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
    Pradhan P; Giri J; Rieken F; Koch C; Mykhaylyk O; Döblinger M; Banerjee R; Bahadur D; Plank C
    J Control Release; 2010 Feb; 142(1):108-21. PubMed ID: 19819275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes.
    Malhi SS; Budhiraja A; Arora S; Chaudhari KR; Nepali K; Kumar R; Sohi H; Murthy RS
    Int J Pharm; 2012 Aug; 432(1-2):63-74. PubMed ID: 22531856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice.
    Yamada A; Taniguchi Y; Kawano K; Honda T; Hattori Y; Maitani Y
    Clin Cancer Res; 2008 Dec; 14(24):8161-8. PubMed ID: 19088031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage.
    Shmeeda H; Tzemach D; Mak L; Gabizon A
    J Control Release; 2009 Jun; 136(2):155-60. PubMed ID: 19331844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation and properties of folate receptor-targeted cationic liposomes].
    Yan Y; Qi XR
    Yao Xue Xue Bao; 2008 Nov; 43(11):1134-9. PubMed ID: 19239034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Clickable" polymer-caged nanobins as a modular drug delivery platform.
    Lee SM; Chen H; O'Halloran TV; Nguyen ST
    J Am Chem Soc; 2009 Jul; 131(26):9311-20. PubMed ID: 19527027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate.
    Yoo HS; Park TG
    J Control Release; 2004 Nov; 100(2):247-56. PubMed ID: 15544872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate receptor-targeted liposomes as vectors for therapeutic agents.
    Gosselin MA; Lee RJ
    Biotechnol Annu Rev; 2002; 8():103-31. PubMed ID: 12436917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted drug delivery to C6 glioma by transferrin-coupled liposomes.
    Eavarone DA; Yu X; Bellamkonda RV
    J Biomed Mater Res; 2000 Jul; 51(1):10-4. PubMed ID: 10813739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
    Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
    J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.